Are cholesterol patients getting the right care? new study aims to find out
NCT ID NCT07606118
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow about 2,500 adults in Italy who have high cholesterol and are at high risk for heart problems. Researchers want to see if their current treatments match official guidelines and how well their cholesterol is controlled over one year. The goal is to find gaps between recommended care and what actually happens in clinics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal where current cholesterol treatments fall short and help doctors improve care for high-risk patients.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test a new drug or therapy, so it cannot directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CVD RISK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new multi-test approach may spot hidden blood vessel damage before symptoms appear
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Greek registry aims to map hidden genetic cholesterol disorder
- Which contact method best warns families of hidden cholesterol danger?
- New combo pill aims to supercharge cholesterol lowering
- New cholesterol drug showdown: could obicetrapib beat bempedoic acid?